1.Analysis on the prognosis factor of nosocomial pneumonia due to Pseudomonas aeruginosa in Southern Hospital during 2006-2009
Lei WU ; Shao-Xi CAI ; Sui-Na GENG ; Lai-Yu LIU ; Wan-Cheng TONG ; Gang LIU
The Chinese Journal of Clinical Pharmacology 2010;26(3):163-166
Objective To investigate on the prognosis factors of nosoco-mial pneumonia due to Pseudomonas aeruginosa in Southern Hospital. Methods By a retrospective study, the date of 136 cases of nosocomial pneumonia due to Pseudomonas aeruginosa in Southern Hospital were ana-lyzed. Results Multivariate Logistic regression analysis identified three independent factors: high clinical pulmonary infection score (CPIS) (OR = 5.01), Lower CPIS at day 5 (OR = 0. 001) and Pan-drug resistance Pseudomonas aeruginosa(OR =28. 80). Lower CPIS at day 5 is a protective factor. Empiric combination antibiotic therapy can increase the frequency of the lower CPIS at day 5. Conclusion High CPIS, lower CPIS at day 5 and Pan-drug resistance Pseudomonas aeruginosa were independent prognostic factors for nosocomial pneumonia due to Pseudomonas aeruginosa.
2.Protective effect of epigallocatechin gallate against sperm abnormality in mice.
Liu-Cai SUI ; Yi-Feng GE ; Juan-Juan XU ; Rong-Hua WU ; Hai-Yan FU ; Bing YAO
National Journal of Andrology 2014;20(12):1068-1072
OBJECTIVETo investigate the protective effect of epigallocatechin gallate (EGCG) on mouse sperm in vivo.
METHODSA total of 64 six-week-old male Kuming mice were randomly divided into eight groups of equal number to be treated with normal saline (negative control), Cyclophosphamide (CP) at 30 mg/kg (positive control), and CP followed by EGCG (experimental) at 20, 40, and 80 mg/kg, respectively, given every other day for 10 days. At 4 and 5 weeks after treatment, the bilateral testes of the mice were harvested for examination of sperm abnormality.
RESULTSEGCG did not increase the rate of CP-induced sperm abnormality in the mice, but reduced it instead with the prolonged time of treatment.
CONCLUSIONEGCG protects mouse sperm in vivo.
Animals ; Catechin ; analogs & derivatives ; pharmacology ; Cyclophosphamide ; toxicity ; Male ; Mice ; Mutagens ; toxicity ; Random Allocation ; Spermatozoa ; drug effects ; Time Factors
3.Clinical trial of salmeterol xinafoate and fluticasone propionate powder for inhalation in the treatment of chronic obstructive pulmonary disease
Yu-Ling SUI ; Xue-Tang LI ; Yu-Cai LIU ; Yan-Li GAO ; Yong-Feng WANG
The Chinese Journal of Clinical Pharmacology 2017;33(11):966-969
Objective To investigate the clinical efficacy and safety of salmeterol xinafoate/ fluticasone propionate in the treatment of chronic obstructive pulmonary disease(COPD).Methods A total of 70 patients with COPD were randomly divided into control group and treatment group,35 cases in each group.Patients in the two groups were all given regular treatment.Patients in the control group were given inhalation treatment with 18 μg tiotropium bromide powder inhalation,qd.Patients in the treatment group were given 50 μg salmeterol fluticasone propionate powder,qd.Patients in the two groups were treated for three cycles (28 days per cycle).The clinical efficacy,pre-and post-treatment of forced vital capacity (FVC),one second forced expiratory volume (FEV1),peak expiratory flow rate value(PEF),FEV1 / FVC,the predicted percentage of FEV1 and PEF value,St.George Hospital Respiratory Questionnaire (SGRQ),multi factor grading system (BODE:body mass index,airflow obstruction,dyspnea and exercise capacity) index score and the incidence of adverse reaction were compared between the two groups.Results After treatment,the total clinical effective rates in the treatment group and the control group were 91.43% (32/35 cases) and 77.14% (27/35 cases),respectively,with statistically significant difference (P<0.05).After treatment,the FEV1 in the treatment group and the control group were(1.86 ± 0.19)L and (1.42 ± 0.17) L,respectively.The FEV1/FVC were (42.93 ± 4.25) % and (39.73 ± 3.68) %,respectively.The PEF were (3.69 ±0.37)L and(3.11 ±0.35)L,respectively.The FEV1/Predicted value were(48.57 ±4.97)% and (44.47 ±4.51)%,respectively.The PEF/ Predicted value were (48.92 ±5.05)% and (41.53 ± 4.55)%,respectively.The SGBQ score were (44.97 ±4.96) and (42.01 ±4.67) points,respectively.The BODE score were (5.98 ±0.59) and (5.67 ± 0.59) points.There were statistically significant differences in all the items above between the two groups(P < 0.05).The adverse drug reactions in the treatment group were headache (1 case),tremor (1 case) and palpitation (1 case),while headache(2 cases),tremor(1 case) and hoarseness(2 cases) were found in the control group.The rates of adverse drug reaction in the treatment group and the control group were 8.57% (3/35 cases) and 14.29% (5/35 cases) respectively,and no statistical significance was found (P > 0.05).Conclusion Salmeterol xinafoate/fluticasone propionate was safe and effective in the clinical treatment of COPD.
4.Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma.
Yu-Sui CHANG ; Ji-Chun LIU ; Hua-Qun FU ; Ben-Tong YU ; Shu-Bing ZOU ; Qi-Cai WU ; Li WAN
Acta Pharmaceutica Sinica 2013;48(5):635-641
Ras is best known for its ability to regulate cell growth, proliferation and differentiation. Mutations in Ras are associated with the abnormal cell proliferation which can result in incidence of all human cancers. Extracellular signal-regulated kinase (ERK) is a downstream effector of Ras and plays important roles in prognosis of tumors. Recently, evidence has gradually accumulated to demonstrate that there are other effectors between Ras and ERK, these proteins interact each other and constitute the thorough Ras/Raf/MEK/ERK signaling pathway. The pathway has profound effects on incidence of esophageal carcinoma and clinical applications of some chemotherapeutic drugs targeting the pathway. Further understanding of the relevant molecular mechanisms of Ras/Raf/MEK/ERK signaling pathway can be helpful for the development of efficient targeting therapeutic approaches which contribute to the treatment of esophageal cancer. In this article, roles of Ras/Raf/MEK/ERK signaling pathway in esophageal carcinoma as well as pharmacological targeting point in the pathway are reviewed.
Animals
;
Antineoplastic Agents
;
pharmacology
;
therapeutic use
;
Carcinoma, Squamous Cell
;
drug therapy
;
enzymology
;
pathology
;
Cell Line, Tumor
;
Enzyme Activation
;
drug effects
;
Esophageal Neoplasms
;
drug therapy
;
enzymology
;
pathology
;
Extracellular Signal-Regulated MAP Kinases
;
antagonists & inhibitors
;
metabolism
;
Humans
;
Mitogen-Activated Protein Kinase Kinases
;
antagonists & inhibitors
;
metabolism
;
Proto-Oncogene Proteins c-raf
;
antagonists & inhibitors
;
metabolism
;
Signal Transduction
;
drug effects
;
ras Proteins
;
antagonists & inhibitors
;
metabolism
5.Correlation between smoking and occurrence of intracranial artery stenosis by ultrasonography:an analysis of multi-center research results
Ran LIU ; Yang HUA ; Lingyun JIA ; Yingqi XING ; Pinjing HUI ; Xuan MENG ; Delin YU ; Xiaofang PAN ; Yalan FANG ; Binbin SONG ; Chunxia WU ; Chunmei ZHANG ; Xiufang SUI ; Youhe JIN ; Jingfen ZHANG ; Jianwei LI ; Ling WANG ; Yuming MU ; Jingxin ZHONG ; Yuhong ZHU ; Heng ZHANG ; Xiaoyu CAI
Chinese Journal of Cerebrovascular Diseases 2017;14(6):297-301,312
Objective To analyze the correlation between smoking and occurrence of intracranial artery stenosis.Methods From June 2015 to May 2016,a total of 10 711 inpatients with transient ischemic attack (TIA) or ischemic stroke from 20 basel hospitals of nationwide were enrolled using a cross-sectional study,76 patients with unknown smoking and smoking cessation years were excluded.Finally,a total of 10 635 patients were enrolled.Transcranial color coded sonography and/or transcranial Doppler were used evaluate the intracranial artery stenosis lesions.The basic risk factors for cerebrovascular disease (age,sex,smoking and smoking years,whether smoking cessation and years,hypertension,diabetes,hyperlipidemia,atrial fibrillation,and family history of stroke) were recorded.According to the different smoking years,the smoking years were divided into five groups:non-smoking,smoking time ≤10-year,11 to 20-year,21 to 30-year,and >30-year groups for trend chi square test.According to the different smoking cessation years in the smokers,the smoking cessation years were divided into four groups:non-cessation,cessation time 1 to 10-year,11 to 20-year,and >20-year groups for trend chi square test.The effects of different smoking years and different smoking cessation years on the occurrence of intracranial arterial stenosis were analyzed.Results The incidence of intracranial artery stenosis in the smokers (40.4%[1 433/3 547]) was significantly higher than that in the non-smoking patients (29.4%[2 085/7 088]).There was significant difference (χ2=128.850,P<0.01),and the incidence of cerebral infarction in the smokers (91.6%[3 250/3 547]) was significantly higher than the non-smokers (85.0%[6 027/7 088]).There was significant difference (χ2=92.328,P<0.01).Smoking was an independent risk factor for intracranial artery stenosis (OR,1.603;95%CI 1.456-1.765;P<0.01).With the increase of smoking years,the detection rate of intracranial arterial stenosis increased gradually (trend χ2=115.437,P<0.01).Whether giving up smoking had no significant effect on the incidence of intracranial artery stenosis in patients with ≥20 years of smoking (trend χ2=1.043,P=0.307).Conclusions Smoking is an independent risk factor for affecting intracranial artery stenosis;the risk of disease increases with the number of smoking years.Long-term smokers (≥20 years) cannot reduce the effect on intracranial artery stenosis,even if they give up smoking.
6.Risk factors for cow's milk protein allergy in infants: a multicenter survey.
Ji-Yong ZHANG ; Shao-Ming ZHOU ; Shao-Hua WANG ; Feng-Xuan SUI ; Wu-Hong GAO ; Qing LIU ; Hua-Bo CAI ; Hong-Ying JIANG ; Wei-Yan LI ; Li-Ting WANG ; Li LI ; Wei ZHAO ; Jing YING ; Qian-Zhen WU ; Bi-Xia WENG ; Yong-Mei ZENG
Chinese Journal of Contemporary Pediatrics 2020;22(1):42-46
OBJECTIVE:
To investigate the risk factors for cow's milk protein allergy (CMPA) among infants through a multicenter clinical study.
METHODS:
A total of 1 829 infants, aged 1-12 months, who attended the outpatient service of the pediatric department in six hospitals in Shenzhen, China from June 2016 to May 2017 were enrolled as subjects. A questionnaire survey was performed to screen out suspected cases of CMPA. Food avoidance and oral food challenge tests were used to make a confirmed diagnosis of CMPA CMPA. A multivariate logistic regression analysis was used to investigate the risk factors for CMPA.
RESULTS:
Among the 1 829 infants, 82 (4.48%) were diagnosed with CMPA. The multivariate logistic regression analysis showed that maternal food allergy (OR=4.91, 95%CI: 2.24-10.76, P<0.05), antibiotic exposure during pregnancy (OR=3.18, 95%CI: 1.32-7.65, P<0.05), and the introduction of complementary food at an age of <4 months (OR=3.55, 95%CI: 1.52-8.27, P<0.05) were risk factors for CMPA, while exclusive breastfeeding (OR=0.21, 95%CI: 0.08-0.58, P<0.05) and the introduction of complementary food at an age of >6 months (OR=0.38, 95%CI: 0.17-0.86, P<0.05) were protective factors.
CONCLUSIONS
The introduction of complementary food at an age of <4 months, maternal food allergy, and antibiotic exposure during pregnancy are risk factors for CMPA in infants.
Animals
;
Cattle
;
China
;
Female
;
Humans
;
Infant
;
Milk Hypersensitivity
;
Milk Proteins
;
Pregnancy
;
Risk Factors
;
Surveys and Questionnaires
7.The application of frozen-thawed blastocyst transfer in patients with diminished ovarian reserve
Qi MING ; Liu-Cai SUI ; Mei-Ling LI ; Qin SUN ; Juan-Juan XU ; Bing YAO ; Yuan-Jiao LIANG
Journal of Medical Postgraduates 2018;31(5):494-499
Objective The embryonic development is usually observed for 5-6 days during the process of embryo culture in most embryonic laboratories.The article aimed to explore the application of D 6+D7 frozen-thawed blastocyst transfer in patients with di -minished ovarian reserve(DOR). Methods Retrospective analysis was conducted on 285 patients with DOR who were treated with in-vitro fertilization and embryo transfer (IVF-ET) in our center from 2015 to 2017.Frozen embryos were harvested from the natural cycle , mini-stimulation protocol, ovulation induction during the luteal phase , followed by frozen-thawed embryo transfer with a total of 442 cycles. The frozen embryos were divided into cleavage embryo group and blas -tocyst group according to different life stages , and comparison was made in general data and pregnancy outcome between the two groups .The blastocyst transfer group was subdivided into Day 5 group and Day6+Day7 group followed by the comparison of different pregnancy outcome between the two groups . Results Patients with DOR were treated with frozen-thawed blastocyst transfer with 291 cycles in cleavage embryo group and 151 cycles in blastocyst group.The implantation rate, clinical pregnancy rate, and ongoing pregnancy rate of blastocyst group were significantly higher than those of cleavage embryo group ( 44.62% vs 22.46%, 50.33% vs 33.33%, 37.75% vs 21.65%, P<0.05) and the abortion rate of blastocyst group was significantly lower than that of cleavage embryo group (35.05% vs 25%, P<0.05).As to the frozen blastocyst transplantation cycle , the number of D5 blastocysts was 69, and D6+D7 blastocyst was 76. The embryo planting rate, clinical pregnancy rate, continued pregnancy rate and abortion rate of D 6+D7 group were higher than those of D5 group(39.74% vs 50%, 44.93% vs 55.26%, 34.78% vs 39.47%, 22.58% vs 28.57%), but the difference was of no statistical significance(P>0.05). Conclusion In patients with DOR, the transplanted blastocyst can significantly improve the pregnancy out -come, increase the clinical pregnancy rate and reduce the abortion rate .The embryo planting rate and clinical pregnancy rate of the transplanted D6+D7 blastocyst were higher than those of D 5 blastocyst, but the difference was not statistically significant .The abortion rate was also increased.Therefore, when the number of embryos is limited, patients with DOR may consider transplanting D 6+D7 high-quality blastocysts in order to get a certain clinical pregnancy rate .
8.Comparison of antibiotic resistance spectrum between methicillin-resistant and methicillin-susceptible coagulase-negative staphylococci nasal isolates among 1 001 HIV infectors
Sui-ping HE ; Jia-ping YE ; Chan BAI ; Ling-hua LI ; Li-ya LI ; Wei-ping CAI ; Ying-ying WANG ; Ying LI ; Wen-cui ZHANG ; Ning LIU ; Zi-jun GONG ; Zhen-jiang YAO
Chinese Journal of Disease Control & Prevention 2019;23(12):1527-1530
Objective We aimed to elucidate the prevalence and the antibiotic resistance spectrum of nasal coagulase-negative staphylococci (CoNS) colonization among HIV infectors in Guangzhou. Method After isolation and identification, all CoNS isolates were tested for the antibiotic susceptibility, and the antibiotic resistance genes. Result Among the 1 001 HIV infectors, the prevalence of CoNS and MRCoNS were 57.44% and 48.15%, respectively. The three predominant resistant antibiotics of MRCoNS isolates were penicillin, erythromycin and trimethoprim-sulfame thoxazole, while predominant detection rates of genes were Aac(6’)-aph(2’)、ermC and linA genes. The multidrug resistance rate of MRCoNS isolates were significantly higher than methicillin-susceptible coagulase-negative staphylococci (MSCoNS) isolates (80.69% versus 39.66%, P<0.001, OR=6.36). Conclusions The prevalence and multidrug resistant rates of nasal colonization CoNS and MRCoNS are high among HIV infectors in Guangzhou. MRCoNS isolates were 6.36 times more likely to be of multidrug resistance than MSCoNS isolates.
9.The mechanism of modified Xiangsha Liujunzi Decoction in regulating apoA-Ⅰ and improving endoplasmic reticulum stress in hyperlipidemic mice
Qi ZHANG ; Guoyuan SUI ; Nan SONG ; Jie WANG ; Yu LIU ; Haoran CAI ; Lianqun JIA
Journal of Beijing University of Traditional Chinese Medicine 2024;47(9):1236-1246
Objective To explore the mechanism of modified Xiangsha Liujunzi Decoction in regulating apolipoproteinA-Ⅰ (apoA-Ⅰ),improving endoplasmic reticulum stress,regulating glucose and lipid metabolism,and preventing and treating dyslipidemia in mice. Methods Wild-type (WT) C57BL/6J mice were randomly divided into the WT,WT+high-fat diet(HFD),and WT+HFD+Xiangsha Liujunzi Decoction(XSLJZ) groups according to the random number table method. ApoA-Ⅰ-/-mice were randomly divided into the apoA-Ⅰ-/-,apoA-Ⅰ-/-+HFD,and apoA-Ⅰ-/-+HFD+XSLJZ groups (n=10) according to the random number table method. D12492 was used for HFD feeding to establish a hyperlipidemic mouse model. Modified XSLJZ (23.66g/kg) was administered daily by gavage from the ninth week. Serum and liver tissue were collected for testing after 4 weeks. An automatic biochemical analyzer was used to detect blood lipid levels;an enzyme-linked immunosorbent assay was used to detect serum fasting blood glucose (FBG) and insulin (INS) levels,and the INS resistance index (HOMA-IR) was calculated. Hematoxylin and eosin staining was used to observe the pathological changes in the liver. Oil red O staining was used to observe the lipid deposition in the liver. TG levels in liver tissue were detected using the microplate method. Real-time PCR was used to detect apoA-Ⅰ,glucose-regulated proteins (GRP78),sterol regulatory element binding protein-1c (SREBP-1c),acetyl CoA carboxylase 1 (ACC1),and fatty acid synthase (FASN) mRNA expression levels in liver tissue. The WES fully automated protein expression analysis system was used to detect apoA-Ⅰ,GRP78,inositol-requiring enzyme 1 (IRE1),p-IRE1,c-Jun N-terminal kinase (JNK),p-JNK,insulin receptor substrate (IRS1),p-IRS1,protein kinase B (Akt),p-Akt,SREBP-1c,ACC1,and FASN protein expression levels in liver tissue. Results Compared to the WT group,the WT+HFD group showed a significant increase in serum lipids,FBG,INS levels,and the HOMA-IR index (P<0.05). The orange-red lipid droplets in liver tissue increased,fat vacuoles were apparent,and TG levels were significantly increased. ApoA-Ⅰ mRNA and protein expression levels were significantly reduced,whereas GRP78,SREBP-1c,ACC1,and FASN mRNA expression levels were increased,GRP78,SREBP-1c,ACC1,and FASN protein levels and the IRE1,JNK,IRS1,and Akt phosphorylation degree were increased (P<0.05). The serum TG,HDL-C,LDL-C,FBG,and INS levels and the HOMA-IR index in the WT+HFD group were significantly reduced after administering modified XSLJZ (P<0.05). The orange-red lipid droplets in liver tissue were significantly reduced,fat vacuolization was alleviated,and TG levels were significantly reduced,ApoA-Ⅰ mRNA and protein expression levels were significantly increased,whereas GRP78,SREBP-1c,ACC1,and FASN mRNA expression levels were reduced,GRP78,SREBP-1c,ACC1,and FASN protein expression levels and the IRE1,JNK,IRS1,and Akt phosphorylation degree were reduced (P<0.05). Compared to the WT+HFD group,the TG,LDL-C,and FBG levels and HOMA-IR index in the serum of the apoA-Ⅰ-/-+HFD group were significantly increased,whereas the HDL-C levels were significantly decreased (P<0.05). Diffuse orange-red lipid droplets in liver tissue and a significant increase in fat vacuoles were observed. Furthermore,TG levels were significantly increased,SREBP-1c,ACC1,FASN mRNA,SREBP-1c,and ACC1 protein expression levels and IRE1,JNK,IRS1,and Akt phosphorylation levels were significantly increased (P<0.05). Compared to the WT+HFD+XSLJZ group,the apoA-Ⅰ-/-+HFD+XSLJZ group showed a significant increase in serum TG,LDL-C,FBG,and INS levels,and the HOMA-IR index,whereas HDL-C levels decreased significantly (P<0.05). The deposition of orange-red lipid droplets in liver tissue improved,and TG levels significantly decreased,GRP78,SREBP-1c,ACC1,and FASN mRNA expression levels,GRP78,SREBP-1c,and ACC1 protein levels,and IRE1,JNK,IRS1,and Akt phosphorylation levels increased (P<0.05). Conclusion Modified XSLJZ improves liver glucose and lipid metabolism disorder by regulating apoA-Ⅰ to alleviate endoplasmic reticulum stress.
10.Genetic characteristics of human acute lymphoblastic leukemia cell line Molt-4.
Xiao-Cai MA ; Cong-Yan LIU ; Xue-Jing SUN ; Jing-Juan HE ; Sui-Gui WAN ; Wan-Ling SUN
Journal of Experimental Hematology 2014;22(2):280-284
This study was aimed to investigate the genetic characteristics of human acute lymphoblastic leukemia cell line Molt-4, and evaluate its application in measuring telomere length by Flow-FISH. Molt-4 cell line was cultured in suspension and subcultured regularly. Eight different passages of Molt-4 cells in exponential stage were selected.The growth curves were drawn by cell counting method, meanwhile calculating the population doubling times of cells,DNA ploidies were determined by flow cytometry,karyotypes were analyzed by G-banding and telomere lengths were measured by Southern blot. The results showed that the population doubling time of Molt-4 cell line was (1.315 ± 0.062) d, DNA ploidy index was (2.085 ± 0.0093) , and the telomere length was (32.05 ± 5.27) kb. There were no significant difference among different passages (P = 0.931,0.888 and 0.935 separately). The karyotypes showed that the chromosome numbers of Molt-4 cell line were from 91 to 99 in different metaphases, and the majority of them were hypertetraploid, and stable and recurrent structural abnormalities of chromosomes could be kept. It is concluded that the stable genetic characteristics and the longer telomere length of Molt-4 cell line makes it be a feasible control cells in measurement of telomere length by Flow-FISH.
Cell Line, Tumor
;
DNA, Neoplasm
;
Flow Cytometry
;
Humans
;
Karyotyping
;
Ploidies
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
genetics
;
Telomere
;
genetics